[go: up one dir, main page]

ZA876970B - Assay method and diagnostic system for a marker of abnormal lipid metabolism - Google Patents

Assay method and diagnostic system for a marker of abnormal lipid metabolism

Info

Publication number
ZA876970B
ZA876970B ZA876970A ZA876970A ZA876970B ZA 876970 B ZA876970 B ZA 876970B ZA 876970 A ZA876970 A ZA 876970A ZA 876970 A ZA876970 A ZA 876970A ZA 876970 B ZA876970 B ZA 876970B
Authority
ZA
South Africa
Prior art keywords
marker
assay method
diagnostic system
lipid metabolism
abnormal lipid
Prior art date
Application number
ZA876970A
Other languages
English (en)
Inventor
S. Smith Richard
M. Hogle Doreen
K. Curtiss Linda
L. Witztum Joseph
Young Steven
Original Assignee
Scripps Clinic And Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scripps Clinic And Research Foundation filed Critical Scripps Clinic And Research Foundation
Publication of ZA876970B publication Critical patent/ZA876970B/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/04Endocrine or metabolic disorders
    • G01N2800/044Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/8215Microorganisms
    • Y10S435/948Microorganisms using viruses or cell lines
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/808Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
    • Y10S530/809Fused cells, e.g. hybridoma

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Fats And Perfumes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Arrangements For Transmission Of Measured Signals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ZA876970A 1986-09-29 1987-09-16 Assay method and diagnostic system for a marker of abnormal lipid metabolism ZA876970B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/913,140 US4828986A (en) 1986-09-29 1986-09-29 Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample

Publications (1)

Publication Number Publication Date
ZA876970B true ZA876970B (en) 1988-03-21

Family

ID=25432962

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA876970A ZA876970B (en) 1986-09-29 1987-09-16 Assay method and diagnostic system for a marker of abnormal lipid metabolism

Country Status (17)

Country Link
US (1) US4828986A (sv)
EP (1) EP0262854B1 (sv)
JP (1) JP2656774B2 (sv)
AT (1) ATE85435T1 (sv)
AU (1) AU611096B2 (sv)
CA (1) CA1285869C (sv)
DE (1) DE3783991T2 (sv)
DK (1) DK173724B1 (sv)
ES (1) ES2053555T3 (sv)
FI (1) FI89214C (sv)
GR (1) GR3008027T3 (sv)
IE (1) IE60119B1 (sv)
IL (1) IL83938A (sv)
NO (1) NO173902C (sv)
NZ (1) NZ221941A (sv)
PT (1) PT85827B (sv)
ZA (1) ZA876970B (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2070820T3 (es) * 1986-08-06 1995-06-16 Scripps Clinic Res Anticuerpos monoclonales especificos de la apolipoproteina b, producidos por dos nuevos hibridomas.
DE3734015A1 (de) * 1987-10-08 1989-04-20 Behringwerke Ag Diagnostisches mittel und verfahren zur bestimmung von apolipoprotein b
AU621575B2 (en) * 1987-11-02 1992-03-19 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
US5759774A (en) * 1988-05-18 1998-06-02 Cobe Laboratories, Inc. Method of detecting circulating antibody types using dried or lyophilized cells
US5183738A (en) * 1988-09-29 1993-02-02 Japan Immuno Research Laboratories Co., Ltd. Kit for the detection of denatured lipoproteins
US5179008A (en) * 1989-02-09 1993-01-12 Wisconsin Alumni Research Foundation Hybridoma and monoclonal antibody to FHAP
US5168045A (en) * 1989-08-18 1992-12-01 The Scripps Research Institute Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
US5473039A (en) * 1989-08-18 1995-12-05 The Scripps Research Institute Polypeptide analogs of apolipoprotein E, diagnostic systems and methods using the analogs
AU662885B2 (en) * 1990-06-07 1995-09-21 Scripps Research Institute, The APO AI polypeptides, antibodies, and immunoassays
AU9088891A (en) * 1990-11-29 1992-06-25 John E. Carbaugh Diagnostic and therapeutic compositions and methods for lipoprotein(a)
EP0559795B1 (en) * 1990-11-30 1995-12-27 Monoclonetics International, Inc. Methods for the diagnosis of chronic lower back and cervical pain
US5844097A (en) * 1990-11-30 1998-12-01 Monoclonetics International, Inc. Methods for the diagnosis of peripheral nerve damage
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
WO1994007146A1 (en) * 1992-09-24 1994-03-31 Perseptive Biosystems, Inc. Quantitative measurement of ldl
US6107045A (en) * 1994-06-30 2000-08-22 Oklahoma Medical Research Foundation Antibodies to lipoproteins and apolipoproteins and methods of use thereof
US5994061A (en) * 1995-09-29 1999-11-30 Queen's University At Kingston DNA constructs and methods for screening for increased expression of human apo AI gene
US5741647A (en) * 1996-02-16 1998-04-21 Tam; Joseph Wing On Flow through nucleic acid hybridisation uses thereof and a device thereof
US6248539B1 (en) 1997-09-05 2001-06-19 The Scripps Research Institute Porous semiconductor-based optical interferometric sensor
US6309844B1 (en) 1997-10-15 2001-10-30 Fujirebio Inc. Anti-apo-B-48 monoclonal antibody, hybridoma producing the same, and method for measuring apo-B-48 using the same
AT5044U1 (de) * 2001-05-10 2002-02-25 Medsystems Diagnostics Gmbh Quantitativer einschritt immuntest in lyophilisierter form
ATE479101T1 (de) * 2001-07-12 2010-09-15 Kyowa Medex Co Ltd Verfahren zur quantifizierung von denaturiertem lipoprotein
CN1864067B (zh) * 2003-10-15 2011-07-06 积水医疗株式会社 试样的前处理方法及使用该方法的免疫学测定方法
US7781171B2 (en) 2003-10-15 2010-08-24 Daiichi Pure Chemicals Co., Ltd. Mehod of pretreating sample and immunological assay method using the same
US7521248B2 (en) * 2007-04-20 2009-04-21 Atherotech, Inc. Apo B measurement system and method
EP3435089A1 (en) 2011-11-11 2019-01-30 Axis-Shield AS Determination of non-hdl cholesterol in blood
CN118047854B (zh) * 2024-02-26 2024-08-02 武汉鹰达生物科技有限公司 一种人载脂蛋白a-i的分离纯化方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2061282B (en) * 1979-10-22 1983-03-30 Symphar Sa Method for the clinical separation of a-and lipoproteins and kit for carrying out this method
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
JPS60193926A (ja) * 1984-03-15 1985-10-02 Tokyo Daigaku 単クローン性抗ヒトアポリポ蛋白質b100抗体
JPS60253871A (ja) * 1984-05-30 1985-12-14 Nippon Koutai Kenkyusho:Kk 抗アポa−1抗体
EP0209543A4 (en) * 1984-12-31 1989-07-11 Internat Genetic Engineering I FRAGMENTS OF HUMAN APOLIPOPROTEINS PEPTIDES, TYPE-SPECIFIC ANTIBODIES AND METHODS OF USE.
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins

Also Published As

Publication number Publication date
DE3783991D1 (de) 1993-03-18
JPS63277968A (ja) 1988-11-15
ES2053555T3 (es) 1994-08-01
FI874253A0 (fi) 1987-09-28
ATE85435T1 (de) 1993-02-15
CA1285869C (en) 1991-07-09
PT85827A (en) 1987-10-01
NO173902C (no) 1994-02-16
PT85827B (pt) 1990-08-31
DK509287D0 (da) 1987-09-28
IE60119B1 (en) 1994-06-01
NO173902B (no) 1993-11-08
DK173724B1 (da) 2001-07-30
GR3008027T3 (sv) 1993-09-30
FI89214B (fi) 1993-05-14
FI874253L (fi) 1988-03-30
NO874056D0 (no) 1987-09-28
EP0262854A2 (en) 1988-04-06
FI89214C (sv) 1993-08-25
IL83938A (en) 1991-12-15
DE3783991T2 (de) 1993-06-09
NO874056L (no) 1988-03-30
AU611096B2 (en) 1991-06-06
AU7902887A (en) 1988-03-31
IE872605L (en) 1988-03-29
DK509287A (da) 1988-03-30
EP0262854A3 (en) 1989-12-06
JP2656774B2 (ja) 1997-09-24
EP0262854B1 (en) 1993-02-03
NZ221941A (en) 1989-05-29
IL83938A0 (en) 1988-02-29
US4828986A (en) 1989-05-09

Similar Documents

Publication Publication Date Title
EP0262854A3 (en) Assay method and diagnostic system for a marker of abnormal lipid metabolism
AU7902987A (en) Hybridomas and monoclonal paratopic molecules to apolipoprotein A-1
CA2200301A1 (en) Method for fractionation of sucrose-containing solutions
Twu et al. Hepatic lipase purification and characterization
Schwartz et al. Mannosidase, glucosidase, and galactosidase in sweet almond emulsin
DE3572303D1 (en) Biologically active substances obtained from bovine casein, process for their preparation and compositions containing them
AU7657387A (en) Apoprotein b-100 specific monoclonal antibodies
Yasuda et al. Genetic polymorphism of human serum ribonuclease I (RNase I)
PT1015568E (pt) Metodo para a producao de rdspa alfa1
Kouvonen et al. The role of sialic acid in the binding of calcium ions to intrinsic factor and its intestinal receptor
ATE76082T1 (de) Reinigungsmethode fuer antikoerper.
Vogel et al. Influence of Fatty Acids on Appearance of Bacterial Phospholipase D in Incubated Plasma
AU3671289A (en) Method for the quantitative determination of gangliosides of the gangliotetraose series by cholera toxin conjugated with an enzyme